Home » Topics » Regulatory » EMA

EMA
RSS

Zonisamide monotherapy approved in E.U., application for pediatric use under review

July 3, 2012

CHMP issues opinion on Zyclara MAA

June 28, 2012

EMA issues scientific opinion on Sanofi Pasteur vaccine

June 28, 2012

CHMP issues opinion on subcutaneous use of Velcade

June 27, 2012

European CHMP issues opinion on Humira for severe axial spondyloarthritis

June 26, 2012

CHMP recommends approval of Afinitor for new indication

June 26, 2012

EMA committee issues opinion on Seebri Breezhaler

June 25, 2012

EMA committee recommends approval of intravenous cephalosporin antibiotic

June 25, 2012

EMA committee issues opinion on taliglucerase alfa

June 25, 2012

Theratechnologies gives update on tesamorelin regulatory progress

June 25, 2012

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 29, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 28, 2026
Chinese biotechs gain leverage as partners in dealmaking
BioWorld
China’s biotech ecosystem has crossed an inflection point, and Chinese biotechs are gaining leverage in dealmaking, executives from multinational companies said...
Plasticity, properly parsed, provides psychiatric platform
BioWorld
If Benjamin Braddock, of The Graduate fame, were a young neuroscientist in the 21st century instead of a liberal arts graduate in 1967, the advice he received...
Roche identifies new TREM2 agonists
BioWorld Science
F. Hoffmann-La Roche Ltd. and Hoffmann-La Roche Inc. have prepared and tested new compounds acting as triggering receptor expressed on myeloid cells 2 (TREM2)...